挤压+套线法子宫肌瘤剔除对妊娠合并子宫肌瘤孕妇剖宫产术临床结局的影响
Influence of Hysteromyoma Removal by Extrusion + Threading on Clinical Outcome of Patients Undergoing Caesarean Section
钟思梅 1曾丽 1郭乐 1胡春芳 1钟小红1
作者信息
- 1. 新余市妇幼保健院妇产科 江西 新余 338000
- 折叠
摘要
目的:研究挤压+套线法子宫肌瘤剔除对剖宫产术患者临床结局的影响.方法:选取2020年3 月—2022 年 12 月新余市妇幼保健院妇产科收治的孕妇 81 例纳入研究,其中妊娠合并子宫肌瘤的孕妇45 例,剖宫产术中用挤压+套线法行子宫肌瘤剔除,归为观察组;将同期行剖宫产无子宫肌瘤的孕妇36 例归为对照组.观察两组术中出血量、术后住院时间、产后出血率、产后发热率差异.结果:观察组术中出血量(289.1±57.2)mL,术后住院时间(4.94±0.60)d;对照组术中出血量(277.5±49.5)mL,术后住院时间(4.86±0.70)d,两组均无产后出血及产后发热,差异均无统计学意义(P>0.05).结论:剖宫产术中行挤压+套线法剔除子宫肌瘤,不会增加术中出血量及产后出血、发热,也不会延长术后住院时间.
Abstract
Objective:To study the influence of hysteromyoma removal by extrusion+threading on clinical outcome of patients undergoing caesarean section.Method:A total of 81 pregnant women in Xinyu Maternal and Child Health Hospital from March 2020 to December 2022 were included in the study.Among them,45 pregnant women with hysteromyoma were included as the observation group,which hysteromyoma were removed with extrusion + threading method during cesarean section;36 pregnant women without hysteromyoma were selected as the control group.The differences of amount of intraoperative bleeding,length of postoperative hospital stay,postpartum hemorrhage rate and postpartum fever rate were observed.Result:In the observation group,the intraoperative bleeding volume was(289.1±57.2)mL,length of postoperative hospital stay was(4.94±0.60)days;in the control group,the intraoperative bleeding volume was(277.5±49.5)mL,length of postoperative hospital stay was(4.86±0.70)days;both groups had no postpartum hemorrhage or fever;the differences were not statistically significant(P>0.05).Conclusion:During caesarean section,extrusion + threading method is used to hysteromyoma removal,which will not increase the amount of intraoperative bleeding,postpartum bleeding,fever,nor prolong the postoperative hospital stay.
关键词
剖宫产/子宫肌瘤剔除/挤压+套线法/出血/发热Key words
Cesarean section/Hysteromyoma removal/Extrusion + threading method/Bleeding/Fever引用本文复制引用
基金项目
江西省卫生健康委普通科技计划(202311808)
出版年
2024